0001123292-20-000198.txt : 20200131
0001123292-20-000198.hdr.sgml : 20200131
20200131172505
ACCESSION NUMBER: 0001123292-20-000198
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200129
FILED AS OF DATE: 20200131
DATE AS OF CHANGE: 20200131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oki Mark K
CENTRAL INDEX KEY: 0001491847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33389
FILM NUMBER: 20566106
MAIL ADDRESS:
STREET 1: C/O ALEXZA PHARMACEUTICALS INC
STREET 2: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VIVUS INC
CENTRAL INDEX KEY: 0000881524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943136179
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 E. HAMILTON AVENUE
STREET 2: SUITE 550
CITY: CAMPBELL
STATE: CA
ZIP: 95008
BUSINESS PHONE: 6509345200
MAIL ADDRESS:
STREET 1: 900 E. HAMILTON AVENUE
STREET 2: SUITE 550
CITY: CAMPBELL
STATE: CA
ZIP: 95008
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-01-29
0000881524
VIVUS INC
VVUS
0001491847
Oki Mark K
C/O VIVUS, INC.
900 E. HAMILTON AVE., SUITE 550
CAMPBELL
CA
95008
0
1
0
0
Chief Financial Officer & CAO
Employee Stock Option (right to buy)
2.21
2020-01-29
4
A
0
32000
0
A
Common Stock
32000
32000
D
(i) One-half of the total number of shares subject to the stock option will vest and become exercisable over four years, such that one-fourth of such shares will vest and become exercisable on January 29, 2021 and an additional one forty-eighth of such shares will vest and become exercisable monthly thereafter over a period of three years following the first anniversary of the date of grant, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2018 Equity Incentive Plan) on the relevant vesting dates; and (ii) one-half of the total number of shares subject to the stock option will vest and become exercisable upon the achievement of both: (a) satisfaction of a performance target involving the Issuer's enterprise value and (b) the passage of at least two years from the date of grant, subject to the reporting person continuing to be a Service Provider upon the achievement of the later of (a) and (b).
The option expires on the earlier of (a) January 29, 2027 and (b) the twelve (12) month anniversary of the date the reporting person ceases to be a Service Provider (as defined in the Issuer's 2018 Equity Incentive Plan).
/s/ John L. Slebir, Attorney-in-Fact
2020-01-31